« Back to news listing

Svelte Medical launches drug-eluting stent trial

Svelte Medical said it launched the Direct II Phase II clinical trial of its drug-eluting stent comparing the device with Medtronic’s Resolute DES. The Svelte device elutes the anti-stenosis drug sirolimus using a bioabsorbable carrier made of amino acids, unlike the polymer-based drug carrier used in the Resolute stent.

Read entire article: http://www.massdevice.com/news/svelte-medical-launches-drug-eluting-stent-trial

« Back to news listing